Sub-classification of intermediate-stage (Barcelona Clinic Liver Cancer stage-B) hepatocellular carcinomas

doi:10.3748/wjg.v21.i37.10604

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 21, Issue 37

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (6769)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Tables (1-2) series.

Item

Count

PDF

538

WORD

199

HTML

3337

Tables (1-2)

163

Sum=4237

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

1282

Download

1250

Sum=2532

Oct 7, 2015 (publication date) through Jul 29, 2024

Times Cited of This Article

Times Cited (15)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Topic Highlight

World J Gastroenterol. Oct 7, 2015; 21(37): 10604-10608
Published online Oct 7, 2015. doi: 10.3748/wjg.v21.i37.10604

Table 1 Substaging of intermediate-stage; Bolondi substaging system

Intermediatesubstage	B1	B2	B3	B4
Child-Pugh score	5-7	5-6	7	8-9
Up-to-7 criterion	In	Out	Out	Any
1^st option	TACE	TACE or TARE		BSC
Alternative	LT	Sorafenib	Research trial	LT
	TACE + Ablation		TACE
	TACE + Ablation		Sorafenib
Median survival time (mo)	41.0	22.1	14.1	17.2

Modification from Reference[9,11]. TACE: Transarterial chemoembolization; TARE: Transarterial radioembolization; LT: Liver transplantation; BSC: Best supportive care.

Citation: Yamakado K, Hirota S. Sub-classification of intermediate-stage (Barcelona Clinic Liver Cancer stage-B) hepatocellular carcinomas. World J Gastroenterol 2015; 21(37): 10604-10608
URL: https://www.wjgnet.com/1007-9327/full/v21/i37/10604.htm
DOI: https://dx.doi.org/10.3748/wjg.v21.i37.10604